WYMONDHAM MEDICAL PARTNERSHIP — All Prescriptions & Medications — Page 3
Practice Code: D82045 | WYMONDHAM, NR18 0RF
Showing results 101-150 of 702
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Lamotrigine | 923 | 60.4K | £8.9K | +56.3% ▲ |
| 888 | 86.8K | £6.1K | +310.6% ▲ | |
| Codeine phosphate | 882 | 69.5K | £2.3K | +22.8% ▲ |
| Linagliptin | 871 | 27.0K | £30.5K | +112.6% ▲ |
| Latanoprost | 844 | 8,045 | £3.3K | +73.9% ▲ |
| Levetiracetam | 789 | 72.4K | £8.7K | +72.4% ▲ |
| Pravastatin sodium | 787 | 30.7K | £1.4K | +142.3% ▲ |
| 773 | 8,210 | £2.2K | +269.8% ▲ | |
| Bimatoprost | 770 | 6,456 | £6.4K | +418.0% ▲ |
| Estriol | 756 | 10.9K | £11.9K | +255.3% ▲ |
| Lorazepam | 737 | 20.5K | £2.8K | +417.0% ▲ |
| Semaglutide | 734 | 21.8K | £62.7K | +204.8% ▲ |
| Ferrous sulfate | 717 | 27.7K | £1.1K | +39.4% ▲ |
| Insulin glargine | 701 | 4,041 | £30.3K | +146.9% ▲ |
| Hydroxocobalamin | 699 | 803 | £1.7K | +45.3% ▲ |
| Senna | 689 | 36.8K | £792 | +14.5% ▲ |
| Beclometasone dipropionate | 679 | 734 | £2.0K | +215.7% ▲ |
| Co-dydramol (Dihydrocodeine/paracetamol) | 669 | 83.5K | £3.8K | +272.3% ▲ |
| Pantoprazole | 648 | 23.4K | £1.1K | +135.7% ▲ |
| Mebeverine hydrochloride | 636 | 56.2K | £1.6K | +104.8% ▲ |
| Diltiazem hydrochloride | 634 | 30.2K | £5.6K | +106.4% ▲ |
| Hydroxychloroquine sulfate | 631 | 33.1K | £1.5K | +225.8% ▲ |
| Hyoscine butylbromide | 620 | 48.2K | £3.7K | +166.0% ▲ |
| Trimethoprim | 612 | 24.1K | £1.4K | +199.5% ▲ |
| Glyceryl trinitrate | 581 | 5,240 | £1.6K | +145.6% ▲ |
| Sodium valproate | 562 | 85.6K | £8.2K | +76.7% ▲ |
| Prochlorperazine maleate | 560 | 21.5K | £1.5K | +177.0% ▲ |
| Sitagliptin | 559 | 18.8K | £1.4K | +43.3% ▲ |
| Dihydrocodeine tartrate | 556 | 53.8K | £3.4K | +184.6% ▲ |
| Digoxin | 555 | 17.8K | £1.3K | +46.6% ▲ |
| Alogliptin | 555 | 17.4K | £15.8K | +118.9% ▲ |
| Clobetasone butyrate | 554 | 27.3K | £3.8K | +171.4% ▲ |
| Carbamazepine | 553 | 54.9K | £3.5K | +86.3% ▲ |
| Etoricoxib | 552 | 20.3K | £4.2K | +585.1% ▲ |
| Thiamine hydrochloride | 548 | 27.7K | £739 | +4.0% ▲ |
| Nifedipine | 544 | 23.4K | £5.5K | +190.3% ▲ |
| Ranolazine | 530 | 34.8K | £6.2K | +211.9% ▲ |
| Irbesartan | 528 | 24.2K | £1.3K | +116.7% ▲ |
| Clarithromycin | 525 | 13.6K | £2.4K | +114.0% ▲ |
| Bumetanide | 522 | 24.4K | £2.3K | +91.6% ▲ |
| Olanzapine | 521 | 13.7K | £1.4K | +40.6% ▲ |
| Pericyazine | 519 | 31.3K | £15.5K | +369.7% ▲ |
| Topiramate | 514 | 33.3K | £2.3K | +189.2% ▲ |
| Lidocaine hydrochloride | 510 | 5,622 | £5.2K | +195.6% ▲ |
| Empagliflozin | 506 | 17.3K | £21.5K | -19.1% ▼ |
| Mesalazine (Systemic) | 504 | 74.7K | £33.3K | +110.4% ▲ |
| Oxycodone hydrochloride | 499 | 82.0K | £11.9K | +95.0% ▲ |
| Loratadine | 494 | 23.6K | £555 | +136.4% ▲ |
| Donepezil hydrochloride | 491 | 16.0K | £2.4K | +59.1% ▲ |
| Sulfasalazine | 489 | 58.9K | £7.8K | +275.7% ▲ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.